Research & Policy

Corporate stories about Research & Policy across 3BL's network.

Latest in Research & Policy

Partnerships Are the New Black
The opportunities to create positive change are all around us and stronger alignment of purpose is bringing us closer together. As a pharmaceutical company, we spend and invest significant resources every day on improving health for millions of people living with diabetes and other serious chronic diseases. But the cause of the diabetes epidemic, and the solutions required to make a change are multidimensional.
Principles in Action: Mars Shares Results on Far-Reaching Health & Sustainability Commitments in New Report
Mars, Incorporated released its sixth annual Principles in Action Summary, spotlighting progress the company has made on commitments in the areas of sustainability, health and wellbeing, food safety, responsible marketing, and workplace engagement. The company’s ‘report card’ reflects the cumulative efforts of its diverse business segments, including Petcare, Chocolate, Wrigley, Food, Drinks and Symbioscience.
Holland America Line Hosts American Cancer Society’s ‘A Toast to Life’ Fundraiser Luncheon on Board ms Amsterdam in Seattle
At a recent fundraising luncheon for Seattle’s American Cancer Society chapter aboard ms Amsterdam, Holland America Line President Orlando Ashford spoke about his company’s commitment to raising money that will save lives and help end cancer. The cruise line hosted the fundraiser Sunday, June 12, at the Port of Seattle as a launch event for Hope Gala, an ASC black-tie celebration, live auction and exclusive dining experience to be held in September featuring Seattle chefs and local vintners.
Sickle Cell Partnership Creates Demonstration Project to Treat Children in Angola
The Angola Sickle Cell Initiative, a public-private partnership of the Angola Ministry of Health, the Baylor College of Medicine International Pediatric AIDS Initiative (BIPAI), Texas Children’s Hospital and Chevron, is teaming up with the global biopharmaceutical company Bristol-Myers Squibb to provide children with sickle cell disease in Angola with an effective medication to which many patients in the country have lacked access.
Preparing to Stop Drug-Resistant Malaria
No child should ever die from a mosquito bite. Yet, today, in an era of extraordinary medical advancement, a child dies of mosquito-borne malaria every two minutes. Last year, this agonizing blood disease caused by the malaria parasite claimed nearly half a million lives—most of them children.

Still, there’s unprecedented cause for optimism. After 15 years of coordinated efforts to fight malaria, we’re seeing progress: Malaria deaths have declined 60 percent since 2000, meaning more than six million lives have been saved. During that same period, an analysis by the Roll Back Malaria initiative shows that 57 countries have reduced malaria cases by 75 percent or more.
2016 GBCHealth Business Action on Health Awards Open Round Two of Categories
The GBCHealth Business Action on Health Awards honor companies that exemplify a spirit of innovation and dedication to outstanding achievements in global health. GBCHealth is pleased to announce that the application process is now open for three additional categories of the 2016 Business Action on Health Awards.
Subaru Gives Back: National Parks, Leukemia & Lymphoma Society Benefit from Automaker
It’s no secret in the world of automotive philanthropy that Subaru is among the most involved, especially as far as Mother Nature is concerned. Its giving arm extends to several pet and animal causes, as well as other environmental concerns.